NOVOCART 3D Treatment Following Microfracture Failure

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2018

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2029

Conditions
Articular Cartilage Defect
Interventions
COMBINATION_PRODUCT

NOVOCART 3D

Matrix associated autologous chondrocyte implant

Trial Locations (5)

43202

Ohio State University Wexner Medical Center, Columbus

60612

Rush University Medical Center, Chicago

84341

Alpine Orthopaedics, North Logan

T6G 2B7

University of Alberta, Edmonton

B3H 2E1

Dalhousie University, Halifax

Sponsors
All Listed Sponsors
lead

Aesculap Biologics, LLC

INDUSTRY

NCT03219307 - NOVOCART 3D Treatment Following Microfracture Failure | Biotech Hunter | Biotech Hunter